Business Description
BioRestorative Therapies Inc
NAICS : 541714
SIC : 8099
ISIN : US0906556065
Total Employee Number:
14Description
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.65 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -55.56 | |||||
Beneish M-Score | -4.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 30.8 | |||||
3-Year EPS without NRI Growth Rate | 30.9 | |||||
3-Year FCF Growth Rate | 11.6 | |||||
3-Year Book Growth Rate | -75.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 94.57 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 101.01 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.96 | |||||
9-Day RSI | 48.13 | |||||
14-Day RSI | 52.55 | |||||
3-1 Month Momentum % | 67.83 | |||||
6-1 Month Momentum % | -56.14 | |||||
12-1 Month Momentum % | -66.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.35 | |||||
Quick Ratio | 2.35 | |||||
Cash Ratio | 2.22 | |||||
Days Sales Outstanding | 16.72 | |||||
Days Payable | 10631.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.1 | |||||
Shareholder Yield % | -20.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.18 | |||||
Operating Margin % | -3973.46 | |||||
Net Margin % | -3088.27 | |||||
EBITDA Margin % | -3914.53 | |||||
FCF Margin % | -3278.71 | |||||
OCF Margin % | -3278.71 | |||||
ROE % | -333.41 | |||||
ROA % | -166.47 | |||||
ROIC % | -448.4 | |||||
3-Year ROIIC % | -81.82 | |||||
ROC (Joel Greenblatt) % | -4166.67 | |||||
ROCE % | -428.98 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 9.7 | |||||
PB Ratio | 3.18 | |||||
Price-to-Tangible-Book | 3.95 | |||||
EV-to-EBIT | 0.24 | |||||
EV-to-EBITDA | 0.24 | |||||
EV-to-Revenue | -9.49 | |||||
EV-to-Forward-Revenue | 1.32 | |||||
EV-to-FCF | 0.29 | |||||
Price-to-GF-Value | 0.25 | |||||
Price-to-Median-PS-Value | 0.17 | |||||
| Price-to-Net-Current-Asset-Value | 3.95 | |||||
| Price-to-Net-Cash | 4.51 | |||||
Earnings Yield (Greenblatt) % | 416.67 | |||||
FCF Yield % | -122.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioRestorative Therapies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.31 | ||
| EPS (TTM) (€) | -0.918 | ||
| Beta | -0.0847 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.44 | ||
| Volatility % | 149.54 | ||
| 14-Day RSI | 52.55 | ||
| 14-Day ATR (€) | 0.032511 | ||
| 20-Day SMA (€) | 0.3264 | ||
| 12-1 Month Momentum % | -66.72 | ||
| 52-Week Range (€) | 0.127 - 1.59 | ||
| Shares Outstanding (Mil) | 25.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioRestorative Therapies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioRestorative Therapies Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 16:30 | In 43 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 42 days | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.16 (-3.13%) | ||
| Annual report for 2025 | 2026-03-26 | 0.26 (+5.69%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-12 16:30 | 1.17 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 1.17 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-08-12 16:30 | 1.15 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-12 | 1.15 (+0.00%) |
Show
Entries
BioRestorative Therapies Inc Frequently Asked Questions
What is BioRestorative Therapies Inc(STU:9OF)'s stock price today?
The current price of STU:9OF is €0.32. The 52 week high of STU:9OF is €1.59 and 52 week low is €0.13.
When is next earnings date of BioRestorative Therapies Inc(STU:9OF)?
The next earnings date of BioRestorative Therapies Inc(STU:9OF) is 2026-08-12 Est..
Does BioRestorative Therapies Inc(STU:9OF) pay dividends? If so, how much?
BioRestorative Therapies Inc(STU:9OF) does not pay dividend.
Press Release
Articles on BioRestorative Therapies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers